Flanimus

Flanimus is a private Israeli health technology company developing a rapid breathalyzer-style diagnostic test for coronavirus detection. Its system uses a disposable capsule containing a chip and a spectrometer to analyze breath samples and identify a viral spectral signature with proprietary software. The company appears to have emerged from the Ben-Gurion University innovation ecosystem and has been described as part of Israel's health tech and life sciences sector. Publicly available information indicates that Flanimus is focused on point-of-care screening rather than therapeutics, with its lead and likely only disclosed program being a low-cost, one-minute COVID-19 diagnostic device. The company appears to remain active as a private limited company in Israel, but there is very limited recent public disclosure on commercialization, financing, or regulatory progress.